APHP, Hôpital Universitaire Charles Foix, Service de Biochimie, Ivry sur Seine, France.
Mol Nutr Food Res. 2010 Jan;54(1):7-16. doi: 10.1002/mnfr.200900437.
Numerous data are now available on the beneficial properties of the polyphenolic compound resveratrol including its anti-inflammatory and antitumor effects. However, few studies have been performed with resveratrol in humans, and the results of these studies appear fragmentary and sometimes contradictory due to variations in conditions of administration, protocols and methods of assessment. This review article presents the results of recent studies investigating the pharmacokinetics, bioavailability, and toxicity of resveratrol in humans. Resveratrol is well absorbed, rapidly metabolized, mainly into sulfo and glucuronides conjugates which are eliminated in urine. Resveratrol seems to be well tolerated and no marked toxicity was reported. These data are important in the context of human efficacy studies, and they provide further support for the use of resveratrol as a pharmacological drug in human medicine.
现在有大量关于多酚化合物白藜芦醇的有益特性的数据,包括其抗炎和抗肿瘤作用。然而,在人类中进行的白藜芦醇研究很少,由于给药条件、方案和评估方法的变化,这些研究的结果显得零散,有时甚至相互矛盾。本文综述了最近研究白藜芦醇在人类中的药代动力学、生物利用度和毒性的结果。白藜芦醇吸收良好,代谢迅速,主要代谢为硫酸和葡萄糖醛酸缀合物,这些缀合物在尿液中排泄。白藜芦醇似乎耐受性良好,没有报告明显的毒性。这些数据在人类疗效研究中很重要,它们进一步支持将白藜芦醇作为一种药物在人类医学中使用。